Dr. Fahad Razak an internist and epidemiologist, with training in health services research and global health. His research focuses on improving the care of hospitalized patients through application of advanced analytic methods to hospital big data. He co-founded GEMINI (https://
Dr Razak completed an Engineering Science degree, Medical Doctorate, and Residency at the University of Toronto. He was the first physician to be appointed the David E. Bell Fellow at Harvard University. Notable research recognitions include the Canadian Society of Internal Medicine’s New Investigator Award and the Graham Farquharson Knowledge Translation Fellowship from the PSI Foundation. He has received >$25 million in grant funding (>$17 million as Principal Investigator) from sources such as CIHR, NSERC, NIH, and the Canadian Cancer Society. He has published 82 peer-reviewed publications (h-index 28, 40 as first/senior author).
He is the Scientific Director of the Ontario COVID-19 Science Advisory Table which informs Ontario’s response to the COVID pandemic. He has co-authored over 40 science and policy briefs that have shaped the policy, public health and clinical response to the COVID-19 crisis.
- Internist and Assistant Professor, St Michael’s Hospital
- Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
- Research Scientist, Li Ka Shing Knowledge Institute
- Provincial Lead, Quality Improvement in General Medicine, Ontario Health
- Scientific Director, Ontario COVID-19 Science Advisory Table
The Canadian COVID-19 Prospective Cohort Study (CANCOV) is a platform observational study that provides a comprehensive evaluation of early to 2-year outcomes in patients with COVID-19 and their family caregivers.